Assessment of the clinical utility of plasma metagenomic next-generation sequencing in a pediatric hospital population

Pharmacology, Toxicology and Pharmaceutical Science

• Antiinfective Agent 100%
• Infection 66%
• Antimicrobial Therapy 66%
• Endocarditis 33%
• Immunocompromised Patient 33%

Keyphrases

• Pediatric Hospital 100%
• Microliter 25%
• Infectious Diseases Consultation 12%
• Plasma Cell-free DNA 12%
• Antimicrobial Duration 12%
• Cell-free DNA (cfDNA) 12%
• Percent Agreement 12%
• Culture-negative Endocarditis 12%
• Immunocompromised Status 12%
• Microbial Cell-free DNA 12%

Medicine and Dentistry

• Metagenomic Next-Generation Sequencing 100%
• Cell-Free DNA 25%
• Endocarditis 12%